Կանադա - անգլերեն - Health Canada

alk-abello inc - dermatophagoides farinae; dermatophagoides pteronyssinus - liquid - 5000unit; 5000unit - dermatophagoides farinae 5000unit; dermatophagoides pteronyssinus 5000unit - allergenic extracts

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

greer laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q) - dermatophagoides farinae 5000 [au] in 1 ml - greer standardized mite ( dermatophagoides farinae and/or dermatophagoides pteronyssinus ) extracts are allergenic extracts indicated for: - skin test diagnosis of mite allergy - treatment of patients with mite-induced allergic asthma, rhinitis and conjunctivitis. for immunotherapy, patients must show hypersensitivity to dermatophagoides farinae ( d. farinae ) or dermatophagoides pteronyssinus ( d. pteronyssinus ) based on their clinical history, allergen exposure history, and skin test reactivity. none. 8.1 pregnancy pregnancy category c: animal reproduction studies have not been conducted with greer standardized mite extracts. it is also not known whether greer standardized mite extracts can cause fetal harm when administered to a pregnant woman or whether they can affect reproduction capacity. standardized mite extracts should be given to a pregnant woman only if clearly needed. studies have not been performed in animals to determine whether extracts affect fertility in males or females,

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata; triticum aestivum; olea europaea; european house dust mite extract; american house dust mite extract; dermatophagoides pteronyssinus body extract; dermatophagoides farinae body extract; lolium perenne; phleum pratense; dactylis glomerata; anthoxanthum odoratum; poa pratensis; cynodon dactylon; mannitol; arrhenatherum elatius; holcus lanatus; avena fatua; bromus inermis; agrostis tenuis; festuca elatior; holcus latanus; cynodon dactylon pollen extract; dermatophagoides farinae body extra -

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

alk-abello, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k) - dermatophagoides farinae 10000 [au] in 1 ml - this product is indicated for the diagnosis and treatment of hypersensitivity in patients with symptoms compatible with dust mite allergy. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. mixtures of standardized mite (d. farinae and d. pteronyssinus) should be considered for treatment of patients who are sensitive to both species. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. there are no known absolute contraindications to immunotherapy. however, a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms and positive skin tests. in most case

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

allergy laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q) - dermatophagoides farinae 10000 [au] in 1 ml - standardized mite extract is used for the diagnosis and treatment of allergic disease to mite. diagnosis of allergic disease to mite is made through a combined medical history sufficiently complete to identify allergic symptoms to mite and identification of mite allergy by diagnostic skin testing. hyposensitization therapy to mite is treatment for patients exhibiting allergic reactions to mite. immunotherapy is intended for patients whose symptoms cannot be satisfactorily controlled by avoidance of the offending allergen or by the use of symptomatic medications. (5) there are no known absolute contraindications to hyposensitization therapy. see precautions section for pregnancy risks. a patient should not be treated with allergens unless a history of symptoms and a positive skin test reaction have been demonstrated. allergenic extracts should only be administered to patients that show symptoms of allergy or asthma. the physician must determine if the benefits outweigh the risks in using these products for tre

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 10 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (chicken (33%), duck (33%), goose (33%) feathers extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 10 ic/ml (equine epithelium extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 10 ic/ml (rumex acetosa pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

antigen laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089), juglans nigra pollen (unii: 1bv28146zr) (juglans nigra pollen - unii:1bv28146zr), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense p - dermatophagoides farinae 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski